NeoImmuneTech, Inc. (KOSDAQ:950220)
1,767.00
-738.00 (-29.46%)
Jun 10, 2026, 3:30 PM KST
NeoImmuneTech Market Cap
NeoImmuneTech has a market cap or net worth of 174.7 billion as of June 10, 2026. Its market cap has decreased by -69.03% in one year.
Market Cap
174.70B
Enterprise Value
124.37B
Revenue
608.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,767.00
Market Cap Chart
Since March 16, 2021, NeoImmuneTech's market cap has decreased from 7.32T to 174.70B, a decrease of -97.61%. That is a compound annual growth rate of -51.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 247.66B | -38.98% |
| Dec 30, 2025 | 405.85B | -27.02% |
| Dec 30, 2024 | 556.13B | -44.44% |
| Dec 28, 2023 | 1.00T | -49.29% |
| Dec 29, 2022 | 1.97T | -61.23% |
| Dec 30, 2021 | 5.09T | -30.48% |
| Mar 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BINEX | 257.97B |
| Anterogen.Co.,Ltd. | 252.65B |
| GC Cell | 247.95B |
| HLB Therapeutics | 233.26B |
| EASY BIO,Inc. | 217.68B |
| Helixmith | 216.42B |
| Bioneer | 196.67B |
| JETEMA, | 179.91B |